1 month ago
India Approves First Dengue Vaccine
India has approved its first dengue vaccine called QDENGA.
This vaccine is made by Takeda Biopharmaceuticals India and is meant to prevent dengue in people aged 4 to 60 years.
The vaccine has been tested in many countries and has been approved in 42 countries, including some in Europe and Asia.
It is given in two doses, three months apart.
The government says this is a big step in fighting dengue in India.
Some people are happy about the vaccine, but others have concerns about its safety and the use of genetically modified organisms.
India has approved its first dengue vaccine, QDENGA, manufactured by Takeda Biopharmaceuticals India.
The vaccine is approved for individuals aged 4 to 60 years and is administered in two doses.
QDENGA has been approved in 42 countries and has received WHO prequalification.
The vaccine has undergone extensive clinical trials and has a favorable safety profile.
The approval is expected to complement ongoing efforts to control dengue in India.
- Who
- The government of India and Takeda Biopharmaceuticals India Pvt Ltd
- What
- Approval of the first dengue vaccine, QDENGA
- Where
- India
- When
- Tuesday (specific date not mentioned)
- Why
- To prevent dengue disease in individuals aged 4 to 60 years
Pro-Vaccination Advocates
Vaccine Skeptics
Vaccine Safety and Efficacy
Pro-Vaccination Advocates
The vaccine has undergone rigorous clinical trials and has been approved in 42 countries, demonstrating its safety and efficacy.
Vaccine Skeptics
Some skeptics question the long-term effects and the use of genetically modified organisms in the vaccine.
Key facts
- Vaccine Name
- QDENGA
- Manufacturer
- Takeda Biopharmaceuticals India Pvt Ltd
- Approval Date
- Tuesday (specific date not mentioned)
- Target Age Group
- 4 to 60 years
- Immunisation Schedule
- Two doses of 0.5 ml each, administered at an interval of three months
- Global Approvals
- 42 countries, including the European Union, the United Kingdom, Switzerland, Indonesia, Malaysia, and Thailand
- WHO Prequalification
- Yes
- Global Doses Distributed
- More than 24 million
Timeline
India OKs dengue vaccine without prior blood test.
Takeda's QDENGA, effective against all four dengue types, approved.
First dengue vaccine for India, after multi-strain outbreaks.
QDENGA cleared for ages 4 to 60.
Quotes
Dr Mahender Nayak
Head of Intercontinental Markets, Takeda
“"Dengue is a growing public health challenge and India needs sustained, evidence-based prevention."”
indianexpress.com
Sources
Related news
Seven AI Courses Offer Paths From Free Lessons to Credentials
IIT Delhi Opens Fourth Batch of Applied AI Certificate Programme
PM Modi to Attend IIT Delhi Convocation, Inaugurate AI Supercomputer
NITK Surathkal Welcomes 1,066 Students to AI-Age B.Tech Curriculum
Bengaluru Engineers Develop Affordable AI PC KEO
UK and Ukraine Open Battlefield AI Partnership Amid War
India, Brazil Agree to Double Trade by 2030
Maharashtra Orders Strict Compliance At Blood Centres After Inspections
India Tightens Sale Rules for Four CNS Drugs
India Requires Sterilisation Licence Numbers On Device Labels
UK TPO Gel Nail Phaseout Raises Indian Safety Questions
